| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 12/31/2008 | EP2007395A1 Cgrp antagonist salt |
| 12/31/2008 | EP1737863B1 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
| 12/31/2008 | EP1727812B1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 12/31/2008 | EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 12/31/2008 | EP1507775B1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 12/31/2008 | EP1435785B1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests |
| 12/31/2008 | EP1309587B1 Cinnoline compounds |
| 12/31/2008 | EP1276741B1 Phenyl substituted 4-hydroxy tetrahydropyridone and its use as pesticide and herbicide |
| 12/31/2008 | EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound |
| 12/31/2008 | CN101336239A Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof |
| 12/31/2008 | CN101336238A Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 12/31/2008 | CN101336237A Pyrimidinyl aryl urea derivatives being fgf inhibitors |
| 12/31/2008 | CN101333213A 1-substituted pyridyl-pyrazol acid amide compounds and use thereof |
| 12/31/2008 | CN101333212A Method for synthesizing triazabenzo[b]fluorine-6-ketones derivates |
| 12/31/2008 | CN101333192A Biaryl substituted pyrazoles as sodium channel blockers |
| 12/31/2008 | CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 12/31/2008 | CN100447134C In-situ treatment of pyridine-2,3-dicarboxylic acid esters with an oxidizing agent |
| 12/31/2008 | CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 12/31/2008 | CA2693226A1 New compounds with antithrombin function and pharmaceutical compositions on their basis |
| 12/31/2008 | CA2692363A1 New anticoagulant compounds, pharmaceutical compositions comprising these compounds for treatment of thrombotic states, and plasma-substituting solutions to correct hypercoagulation defects of hemodilution |
| 12/31/2008 | CA2691932A1 Use of compounds for preparing anti-tuberculosis agents |
| 12/31/2008 | CA2691857A1 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| 12/31/2008 | CA2691849A1 Kallikrein 7 modulators |
| 12/31/2008 | CA2691215A1 Pyrazinone derivatives and their use in the treatment of lung diseases |
| 12/31/2008 | CA2690378A1 Phthalazine compounds, compositions and methods of use |
| 12/31/2008 | CA2690064A1 Benzimidazole amido derivatives as kinase inhibitors |
| 12/31/2008 | CA2689109A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
| 12/31/2008 | CA2686224A1 Piperazine compounds having herbicidal action |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470790 for treatment of various neurodegeneration, including that from stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease; [6-(1-benzyl-4-hydroxy-pyrrolidin-3-ylmethyl)-pyridin-2-yl]-carbamic acid tert-butyl ester |
| 12/30/2008 | US7470787 Kinase inhibitors; anticarcinogenic agents; obesity, glaucoma; N-(4-(3-(isoquinolin-6-ylamino)-3-oxopropyl)phenyl)-4-methoxybenzamide |
| 12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 12/30/2008 | US7470716 Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
| 12/30/2008 | US7470713 Imidazole based kinase inhibitors |
| 12/30/2008 | US7470712 Amino-benzazoles as P2Y1 receptor inhibitors |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/30/2008 | US7470709 Benzimidazole quinolinones and uses thereof |
| 12/30/2008 | US7470708 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 12/30/2008 | US7470704 Benzonaphthyridines |
| 12/30/2008 | US7470702 Benzimidazoles |
| 12/30/2008 | US7470701 e.g. 3-(4-fluorophenyl)-N-{5-[2-(methylamino)pyrimidin-4-yl]thien-2-yl}propanamide; PKB/Akt kinase inhibitor; anticarcinogenic agent; carcinoma, cancer metastases, squamous cell carcinoma, esophageal squamous cell carcinoma, oral carcinoma, cutaneous T cell lymphoma, Hodgkin's lymphoma |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/30/2008 | US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 12/30/2008 | US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis |
| 12/30/2008 | US7470681 Pyrimidine compounds |
| 12/30/2008 | US7470680 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (9-benzyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(R)-cyclohepta[e]inden-7-yl)-amide; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, menopause, asthma |
| 12/30/2008 | US7470679 Constrained compounds as CGRP-receptor antagonists |
| 12/30/2008 | CA2441771C Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i |
| 12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 12/30/2008 | CA2294243C Novel cyanoaziridines for treating cancer |
| 12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
| 12/30/2008 | CA2178062C Improved process for the manufacture of 5-(alkoxymethyl)pyridine-2,3-dicarboxylate salt |
| 12/25/2008 | US20080319195 Enantioselective Preparation of Benzimidazole Derivatives and Their Salts |
| 12/25/2008 | US20080319188 Novel pyridine derivatives and pyrimidine derivatives (3) |
| 12/25/2008 | US20080319046 Substituted sulfonamide-indoles |
| 12/25/2008 | US20080319021 Inhibition Of Phosphoinositide 3-Kinase Beta |
| 12/25/2008 | US20080319019 Therapeutic Agents |
| 12/25/2008 | US20080319018 Organic compounds |
| 12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
| 12/25/2008 | US20080319012 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 12/25/2008 | US20080319011 Protein tyrosine kinase enzyme inhibitors |
| 12/25/2008 | US20080319005 Phenylacetamides Suitable as Protein Kinase Inhibitors |
| 12/25/2008 | US20080319003 Cyclic amine compound and pest control agent |
| 12/25/2008 | US20080319001 Cancer Treatment Using Specific 3,6,9-Substituted Acridines |
| 12/25/2008 | US20080318979 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 12/25/2008 | US20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists |
| 12/25/2008 | US20080318975 Prevent transplant rejection |
| 12/25/2008 | US20080318974 Such as 1-[2-(piperidin-3-ylmethoxy)-5-trifluoromethyl-phenyl]-3-(5-trifluoromethyl-pyrazin-2-yl)-urea hydrochloride salt; checkpoint kinase (Chk1) inhibitors; cancer; diseases characterized by defects in DNA replication, chromosome segregation and/or cell division |
| 12/25/2008 | US20080318968 Chemical Compounds |
| 12/25/2008 | US20080318958 New utilities of tricyclic compounds |
| 12/25/2008 | US20080318954 Compounds |
| 12/25/2008 | US20080318952 Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators |
| 12/25/2008 | US20080318951 Dual-acting benzoimidazole antihypertensive agents |
| 12/25/2008 | US20080318950 Quinazoline Derivatives as a Multiplex Inhibitor and Method For the Preparation Thereof |
| 12/25/2008 | US20080318948 activators of glucokinase activity such as (R)-3-Cyclopentyl-N-isoquinolin-1-yl-2-[4-(4-methyl-piperazine-1-sulfonyl)-phenyl]-propionamide, used for the prevention and the treatment of diabetes, non-insulin dependent diabetes and obesity |
| 12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 12/25/2008 | US20080318941 4' substituted compounds having 5-ht6 receptor affinity |
| 12/25/2008 | US20080318933 5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders |
| 12/25/2008 | US20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta |
| 12/25/2008 | US20080318927 Substituted monocyclic CGRP receptor antagonists |
| 12/25/2008 | US20080318924 Phenoxypyridine derivative salts and crystals thereof, and process for preparing the same |
| 12/25/2008 | US20080318923 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle |
| 12/25/2008 | US20080318922 Bicyclic Pyrrole Derivatives |
| 12/25/2008 | US20080318902 Triheterocyclic compounds and compositions thereof |
| 12/25/2008 | US20080318899 Pyridazine Compounds, Compositions and Methods |
| 12/25/2008 | US20080317744 Indole and Benzimidazole Derivatives |
| 12/25/2008 | US20080317712 Arylpiperidinyl and arylpyrrolidinyl tripeptide hepatitis c serine protease inhibitors |
| 12/25/2008 | US20080317676 Biocompatible Fluorescent Imaging Agents |
| 12/25/2008 | US20080317671 Non-imidazole heterocyclic compounds |
| 12/24/2008 | WO2008157575A1 Protein kinase inhibitors and methods for using thereof |
| 12/24/2008 | WO2008157500A1 Aminoquinazoline cannabinoid receptor modulators for treatment of disease |
| 12/24/2008 | WO2008157407A2 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 12/24/2008 | WO2008157404A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 12/24/2008 | WO2008157191A2 Quinazoline derivatives as pi3 kinase inhibitors |
| 12/24/2008 | WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors |